Sign in to view content

Are There Safety Concerns With Bevacizumab for ROP

Robert L. Avery, MD

Video
Published 2017

Related

Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022
Laser Photocoagulation for Type 2 Retinopathy of Prematurity (ROP) or Less: When and Why?
Edward H. Wood, MD, FASRS
Annual Meeting Talks
2020
Pediatric Case Conference: Limbal Vitreoretinal Surgery for Stage 5 Traction Retinal Detachment in Mystery Syndrome
Yoshihiro Yonekawa, MD, FASRS
Annual Meeting Talks
2024

Category: Pediatric Retina - ROP

See more